Federal Register of Legislation - Australian Government

Primary content

PB 50 of 2023 Determinations/Health as made
This instrument amends the National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022) to increase existing brand premiums for specified drugs, implement a new brand premium for one pharmaceutical item, remove one brand premium from one pharmaceutical item, and remove three pharmaceutical items with brand premiums that are delisting from the Pharmaceutical Benefits Scheme on 1 June 2023.
Administered by: Health and Aged Care
Registered 31 May 2023
Tabling HistoryDate
Tabled HR13-Jun-2023
Tabled Senate13-Jun-2023
Date of repeal 05 Sep 2023
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003